Erratum to: Diagnosis and treatment of vertigo and dizziness: Interdisciplinary guidance paper for clinical practice (HNO, (2025), 73, S3, (357-369), 10.1007/s00106-025-01599-z)

Abstract

In Table 3 of this article, entries in the second column/heading “Drug treatment/Acute phase/symptomatic” were incorrect. The text was incorrecty given as “May be considered: antiemetics (domperidone, metoclopramide, ondansetron) and/or antivertiginous drugs (cinnarizine ± dimenhydrinate) for a max. of 2–3 days, Ginkgo biloba extract (EGb 716) to support central adaptation [28, 29]” but should have been “May be considered: antiemetics (domperidone, metoclopramide, ondansetron) and/or antivertiginous drugs (cinnarizine ±dimenhydrinate) for a max. of 2–3 days, Ginkgo biloba extract (EGb 761) to support central adaptation [28, 29]”. Supplementary file: In Table S1, Term “Acute imbalance syndrome (AIS)” the Definition should have read “… without spontaneous or gaze-evoked nystagmus” instead of “… with spontaneous or gaze-evoked nystagmus”. The original article has been corrected.